整体纵向应变:胸部放疗肺癌患者放射性心功能不全早期检测的潜在无创工具
该回顾性研究评估了整体纵向应变(GLS)在胸部放疗肺癌患者中早期检测放射性心功能不全(RICD)的潜力及其与生存的关系。结果显示放疗后异常GLS比例从31.6%升至57.9%(P=.012),且各腔室GLS较基线均显著下降(P<.001),而左心室射血分数无显著变化。放疗后异常GLS患者生存更差(单因素P=.049,多因素P=.063)。
要点
- 胸部放疗后GLS显著下降,而左心室射血分数无显著变化。
- 放疗后异常GLS比例从31.6%升至57.9%(P=.012)。
- 放疗后异常GLS患者生存更差(单因素P=.049,多因素P=.063)。
核心结论
- 标准超声心动图可检测到GLS的不良变化,且在此高危肺癌胸部放疗队列中先于左心室射血分数的显著变化。
- 超声心动图衍生的GLS有潜力作为该人群RICD的早期无创标志物,并可能有助于早期采用GLS指导的心脏保护治疗。
研究设计与样本
- 回顾性分析原发性或继发性肺癌患者,接受标准胸部放疗且平均心脏剂量≥5 Gy,放疗前后超声心动图有可测量GLS。
主要发现
- 放疗前异常GLS(定义为<18%或较正常基线相对下降>15%)占31.6%,放疗后占57.9%(P=.012)。
- 放疗后2腔、3腔、4腔及平均GLS较基线的中位绝对下降分别为1.90(IQR 4.43)、3.00(IQR 3.83)、2.50(IQR 3.63)、2.25(IQR 3.53),均P<.001。
- 放疗后左心室射血分数无统计学显著变化。
- 单因素分析显示放疗后异常GLS患者生存显著差于正常GLS患者(P=.049)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation-induced cardiac dysfunction (RICD) is a competing cause of morbidity and mortality in patients receiving thoracic radiation therapy (RT). Currently, there are no clinically-validated approaches for early detection of RICD at a time point that affords the potential for mitigation. The goal of this study was to evaluate the potential of global longitudinal strain (GLS) derived from standard-of-care echocardiogram (ECHO) for the early detection of RICD and to assess the association between adverse GLS changes and survival in patients receiving thoracic RT. METHODS AND MATERIALS: A retrospective review of changes in GLS was carried out in patients with primary or secondary lung cancer who received standard-of-care thoracic RT with a mean heart dose of ≥5 Gy and had measurable GLS on ECHOs performed before and after RT. Changes in 2-chamber (2C), 3-chamber (3C), and 4-chamber (4C) GLS and peak average GLS after RT (relative to pre-RT baseline) were quantified. Survival probabilities were estimated in patients with normal versus abnormal GLS. RESULTS: Thirty-eight patients had measurable GLS before and after RT. Abnormal GLS (defined as <18% or >15% relative decline in GLS after RT from a normal baseline value) was present in 31.6% of patients before RT and 57.9% of patients after RT (P = .012). On paired comparisons, the absolute median reduction (IQR) in 2-chamber, 3-chamber, 4-chamber, and average GLS after RT relative to pre-RT baseline was 1.90 (4.43), 3.00 (3.83), 2.50 (3.63), and 2.25 (3.53), respectively, all P < .001. No statistically significant change in left ventricular ejection fraction was noted after RT. Patients with abnormal GLS after RT had significantly worse survival than those with normal GLS on univariable analysis (P = .049). Despite the small sample size of the study, the survival detriment in patients with abnormal GLS after RT strongly trended toward significance on multivariable analysis (P = .063). CONCLUSIONS: Adverse changes in GLS are detectable on standard-of-care ECHOs and precede significant changes in left ventricular ejection fraction in this cohort of high-risk patients with primary and secondary lung cancer receiving thoracic RT. Thus, ECHO-derived GLS has the potential to serve as an early and noninvasive marker of RICD in this patient population and may enable early adoption of GLS-guided cardioprotective therapy, which has been shown to mitigate cardiac dysfunction in patients with cancer receiving cardiotoxic treatments.
引用
- Montalvo SK, Lue B, Kakadiaris E, et al. Global Longitudinal Strain: A Potential Noninvasive Tool for Early Detection of Radiation-Induced Cardiac Dysfunction in Patients With Lung Cancer Receiving Thoracic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2025. PMID: 40174646. doi:10.1016/j.ijrobp.2025.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。